Stryker Corporation (NYSE:SYK) to Issue $0.88 Quarterly Dividend

Stryker Corporation (NYSE:SYK) declared a quarterly dividend on Thursday, May 7th. Shareholders of record on Tuesday, June 30th will be given a dividend of 0.88 per share by the medical technology company on Friday, July 31st. This represents a c) annualized dividend and a dividend yield of 1.2%. The ex-dividend date of this dividend is Tuesday, June 30th.

Stryker has raised its dividend payment by an average of 0.1%annually over the last three years and has raised its dividend annually for the last 32 consecutive years. Stryker has a dividend payout ratio of 23.7% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Stryker to earn $16.63 per share next year, which means the company should continue to be able to cover its $3.52 annual dividend with an expected future payout ratio of 21.2%.

Stryker Price Performance

Shares of SYK traded down $4.05 during midday trading on Friday, hitting $290.18. 196,605 shares of the company traded hands, compared to its average volume of 2,111,259. The firm has a 50 day moving average of $340.37 and a 200-day moving average of $355.17. Stryker has a 52 week low of $289.70 and a 52 week high of $404.87. The stock has a market cap of $111.13 billion, a price-to-earnings ratio of 33.58, a PEG ratio of 1.84 and a beta of 0.80. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.25 and a current ratio of 2.11.

Stryker (NYSE:SYK) last released its quarterly earnings data on Thursday, April 30th. The medical technology company reported $2.60 EPS for the quarter, missing the consensus estimate of $2.98 by ($0.38). Stryker had a net margin of 13.20% and a return on equity of 23.42%. The company had revenue of $6.02 billion for the quarter, compared to the consensus estimate of $6.34 billion. During the same period last year, the company earned $2.84 EPS. The firm’s revenue for the quarter was up 2.6% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. On average, analysts forecast that Stryker will post 14.98 EPS for the current fiscal year.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.